BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 25725444)

  • 1. Bridging the gap between host immune response and intestinal dysbiosis in inflammatory bowel disease: does immunoglobulin A mark the spot?
    Shapiro JM; Cho JH; Sands BE; LeLeiko NS
    Clin Gastroenterol Hepatol; 2015 May; 13(5):842-6. PubMed ID: 25725444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis.
    Ray A; Dittel BN
    Immunology; 2015 Nov; 146(3):359-68. PubMed ID: 26211540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.
    Rengarajan S; Vivio EE; Parkes M; Peterson DA; Roberson EDO; Newberry RD; Ciorba MA; Hsieh CS
    Gut Microbes; 2020 May; 11(3):405-420. PubMed ID: 31203722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease.
    Shapiro JM; de Zoete MR; Palm NW; Laenen Y; Bright R; Mallette M; Bu K; Bielecka AA; Xu F; Hurtado-Lorenzo A; Shah SA; Cho JH; LeLeiko NS; Sands BE; Flavell RA; Clemente JC
    Cell Host Microbe; 2021 Jan; 29(1):83-93.e3. PubMed ID: 33385335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg?
    Fritsch J; Abreu MT
    Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):381-393. PubMed ID: 31078242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
    Kang M; Martin A
    Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J; Gardlik R
    World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human umbilical cord mesenchymal stem cells regulate immunoglobulin a secretion and remodel the diversification of intestinal microbiota to improve colitis.
    Liu A; Wang X; Liang X; Wang W; Li C; Qian J; Zhang X
    Front Cell Infect Microbiol; 2022; 12():960208. PubMed ID: 36118029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut microbiota and inflammatory bowel disease.
    Matsuoka K; Kanai T
    Semin Immunopathol; 2015 Jan; 37(1):47-55. PubMed ID: 25420450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
    Robinson AM; Gondalia SV; Karpe AV; Eri R; Beale DJ; Morrison PD; Palombo EA; Nurgali K
    Inflamm Bowel Dis; 2016 Dec; 22(12):2767-2787. PubMed ID: 27824648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral immune responses against gut bacteria in dogs with inflammatory bowel disease.
    Soontararak S; Chow L; Johnson V; Coy J; Webb C; Wennogle S; Dow S
    PLoS One; 2019; 14(8):e0220522. PubMed ID: 31369623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice.
    Aguilera M; Cerdà-Cuéllar M; Martínez V
    Gut Microbes; 2015; 6(1):10-23. PubMed ID: 25531553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor-mediated Dysbiosis.
    Pickert G; Wirtz S; Matzner J; Ashfaq-Khan M; Heck R; Rosigkeit S; Thies D; Surabattula R; Ehmann D; Wehkamp J; Aslam M; He G; Weigert A; Foerster F; Klotz L; Frick JS; Becker C; Bockamp E; Schuppan D
    Gastroenterology; 2020 Jul; 159(1):257-272.e17. PubMed ID: 32251667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compositional Changes in the Gut Mucus Microbiota Precede the Onset of Colitis-Induced Inflammation.
    Glymenaki M; Singh G; Brass A; Warhurst G; McBain AJ; Else KJ; Cruickshank SM
    Inflamm Bowel Dis; 2017 Jun; 23(6):912-922. PubMed ID: 28498157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral microbiome composition changes in mouse models of colitis.
    Rautava J; Pinnell LJ; Vong L; Akseer N; Assa A; Sherman PM
    J Gastroenterol Hepatol; 2015 Mar; 30(3):521-7. PubMed ID: 25180790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota alterations in acute and chronic gastrointestinal inflammation of cats and dogs.
    Honneffer JB; Minamoto Y; Suchodolski JS
    World J Gastroenterol; 2014 Nov; 20(44):16489-97. PubMed ID: 25469017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
    Satokari R
    Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.